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MR with different degree of local and global LV remodeling. and characteristics of the 
regurgitant jet. Such, a complete characterization of the pattern of ischemic MR could aid 
to tailor the best treatment for the single patient 
1084-22 Papillary Muscle Dysfunction Attenuates lschemic 
Mitral Regurgitation in Patients With Localized Basal 
Inferior Left Ventricular Remodeling 
Takeshi Uemura, Yutaka Otsuji, Toshiro Kumanohoso, Kunitsugu Takasaki, Toshinon 
Yuasa, Woo-Shik Kim, Akira Klsanuki, Shinichi Minagoe, Robert A. Levine, Chuwa Tei, 
Kagoshima University, Kagoshima, Japan, Massachusetts General Hospital, Boston, MA 
Background: In principle, papillary muscle (PM) dysfunction could be associated with 
less mitral regurgitation (MR) because of PM elongation, attenuating tethering. However, 
variability in the degree of left ventricular (LV) remodeling can influence the relation 
between PM dysfunction and MR. We. therefore, hypothesized that PM dysfunction 
attenuates MR in patients with comparable degree of segmental basal inferior LV remcd- 
cling. 
Method: From 38 consecutive patients with previous inferior myocardial infarction. 2 
patients with global LV remodeling and 12 with only modest inferior remodeling were 
excluded. In the remaining 24 patients with significant and localized basal inferior LV 
remodeling, LV volume, mitral annular area, PM tethering distance, % systolic thickening 
of middle p&ion of medial PM and MR fraction were quantified by 2.dimensional and 
Doppler echocardiography. 
Results: % systolic PM thickening had positive and significant relation with % MR fraction 
(figure), which was best correlated with medial PM tethering distance. 
Conclusion: lschemic MR can be attenuated by PM dysfunction, reducing leaflet tether- 
Ing, in patients with localized basal inferior LV remodeling. 
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1084-23 Inhibition of the cJun N-Terminal Kinase Pathway 
Minimizes Collagen Remodeling in Aortic Regurgitant 
Hearts 
Eungsuk Lee, Sharada L. Truter, Lisa Pitlor, Zhen Huang. Anuj Gupta, Jeffrey S. Borer, 
Weill Medical College, Cornell Unwersity, New York, NY 
Background: Fibrosis associated with aortic regurgitatton (AR) shows abnormal 
fibronectin (FN) but normal collagen content. This pathologic fibrosis is important in gen- 
esis of heart failure (CHF) in AR; understanding fibrosis generation may enable specific 
therapy to retard CHF. We showed that increased FN expression by cardiac fibroblasts 
(CF) from rabbits with catheter-induced AR results from activation of the c-Jun N-terminal 
kinase (JNK) pathway, which also can upregulate collagen-specific metalloproteases 
(MMPs). To see if JNK activation of MMP is involved in minimizing collagen content in 
AR we assessed MMP-2 activity with SP600125, a specific JNK inhibitor. Methods: NL- 
CF vs AR-CF (3 pairs) from rabbits were grown in triplicate with and without 2Ofl 
SP600125. Media then were collected for 24 hr intervals wer 5 days. Enzymes were 
separated by gelatin-containing zymograms, stained with coomassie blue, destained, 
and analyzed by videodensitometry. Band intensities were normalized to total cell protein 
concentrations. Results: MMP-2 activity was upregulated in AR-CF vs NL-CF 
(AR:NL=2.1:1. p< .03). When CF were grown with SP600125, MMP-2 activity was maxi- 
mally downregulated by day 2 vs day 0 (NL, 1.0:0.4, p< ,001; AR, 1.0:0.5. p< ,001. 
Table). Conclusion In AR myocardium, fibrotic myocardium featuring abnormal FN but 
normal collagen content results in part from AR-Induced upregulation of MMP-2 by JNK 
stimulation. Inhibition of this reaction may help mitigate pathologic fibrosis and CHF. 
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1 2 3 4 5 
Exposure Day(N) + 
Cell Line J 
NLl 1:0.4 1:0.5 1:0.7 
NL2 1:O.E 1:0.3 1:0.6 
NL3 1:0.7 t :0.3 1:0.4 
Average 1:0.6 1:0.4 1:0.5 
AR1 1:0.5 1:0.2 1:0.5 
AR2 1:o.g 1:0.6 1:0.7 
AR3 1:o.g 1:0.2 1:0.4 
Average 1:O.B 1:0.5 1:0.6 
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1084-24 Heterogeneity of Response to Pressure Overload in 
Aortic Stenosis 
Danita M. Yoeraer, Marcia B. Leavitt, Michael H. Picard, Massachusetts General 
Hospital, Harvard Medical School, Boston, MA 
Left ventricular hypertrophy IS a ccmmcn response to the pressure overload conditions of 
acttic stenosis. The precise nature of this relationship, however has yet to be elucidated. 
Methods: We identified 265 patients referred for routine transthoracic echocardiography 
in the past 9 months who were found to have aortic stenosis with an aortic valve area 
<l .O cn? and normal regional wall motion. Patients were excluded if they had LV cavity 
dilatation suggestive of eccentric hypeltrophy (n=99) or inadequate echocardiography to 
perform the analysis(n=lO). We assessed septal wall thickness(lVS), posterior wall thick- 
ness (PWT), chamber dimensions, ejection fraction, aortic gradients, aortic valve area, 
and calculated left ventricular mass. Correlation coefficients were calculated to examine 
the relationship between wall thicknesses and peak pressure gradients(PKGR). Results: 
Of the 175 patients included in this analysis, 49% were men, and the mean age was 74 
+I- 0.9 years. While significant correlation coefficients were demonstrated for the rela- 
tionship between IVS and PKGR (R=0.27, p<O.O003), between PWT and PKGR 
(R=0.30, p<O.OOOl), and between LV mass and PKGR (R=O.26, P<O.O005), a large per- 
centage of patients failed to demonstrate hypedrophy at significant pressure gradients 
(Fig 1). Conclusion: The hypertrophic response to pressure overload in aortic stenosis 
appears heterogeneous. Other factors which influence ventricular remodeling may play a 
role in this process. 
1084-25 Effect of Candesartan Cilexetil on Left Ventricular 
Remodeling in Mitral Regurgitation: A Randomized 
Clinical Trial 
Maurice L. Enriquez-Sarano, Michael Bellamy, Jean-Francois Avierinos David L. (- 
Messika-Zeitouq Vuysile Nkomo. Mayo Clinic, Rochester, MN 
Background:The effect of tissue angiotensin blockade in Mitral Regurgitation (MR) due 
to intrinsic valve disease is disputed due to lack of randomized clinical trials. Of particular 
importance is the effect of these medications on left ventricular (LV) remodeling, ie.. on 
LV end-diastolic and end-systolic volume index (EDVI, ESVI). Candesartan Cilexetil is an 
anglotensin receptor blocker with insurmountable receptor attachment allowing prc- 
longed clinical efficacy. 
Methods: In 32 patients (age 69+14 years, 36% female) with organic MR of at least 
moderate degree, in functional Class I or II, with normal renal function (creatinine 1.1+0.2 
mg/dL), patients were randomized between placebo (n=l7) or Candesartan Cilexetil 32 
mg/daily (n=l5) treatment for 1 year. After one year the end-points of EOVI and ESVI 
were measured. 
Results:At baseline, there was no difference between placebo and Candesartan groups 
forage, sex. systolic (141*19 vs. 144i18 mmHg, P=O.69) and diastolic (74+10 vs. 77+14 
mmHg, P=O.46) blood pressure, regurgitant volume measured by 2 methods (73*25 vs. 
77*14 ml/beat, P=O.97), EDVI (103221 vs. 104+19 mUm2,) and ESVI (26+9 vs. 25tlO 
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mUm2, P=O.64). After one year of treatment, the systolic blood pressure decreased in 
both groups (P=O.O4 and <O.OOl respectively but the placebo showed less decline than 
the Candesarian group (-8.6i16 vs. -21.5&‘0 mmHg, P<O.OOl). Hence, the systolic wall 
stress declined in the Candesartan group (-26*44 glcm2, P=O.O5) but remained 
unchanged in the placebo group (P=O.l9). The change in ejection fraction or in the end- 
systolic wall stress to volume index ratio were not different between groups (P=O.82 and 
0.70 respectively). However, the change in EDVI was in opposite direction and signifi- 
cantly different between placebo and Candesanan (+3.&E vs. -3.5i9 mUm2, P=O.O2) 
and similarly the increased of ES/l was larger with placebo than Candesatian (+6.2*6.2 
vs. +0.6*7 mUm2, P=O.O2). 
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Conclusion: The administration of Candesatian Cilexetil 32 mg daily in patients wth 
organic MR compared to placebo results in l-larger decline in blood pressure, P-larger 
decline in wall stress, 3-decline versus increase in EDVI and 4-lesser increase in ESVI. 
806-l Impact of Age on Pathology, Treatment, and Outcome in 
Degenerative Mitral Valve Disease 
1084-26 Left Ventricular Remodeling Differs in Chronic Aortic 
Insufficiency and Mitral Regurgitation Following 
Surgical Correction 
Kameswan Maqanti, Nawaid M. Shakir, Beverly Smulevitz, Bonme J. Kane, Ashwin 
Nagaraf, David A. Fullerton, Robert 0. Bonow, David D. McPherson, Vera H. Rigolin, 
Northwestern University Chicago, IL 
Background: Chronic aortic regurgitation (AR) and mitral regurgitation (MR) impose a 
progressive hemodynamic burden on the left ventricle, often necessitating surgical car- 
rection. To compare left ventricular (LV) remodeling after aortic valve replacement vs 
mitral valve rapa~r, we assessed the morphologic changes of the left ventricle using two- 
dimensional echocardiography. 
Methods: The AR group (n=6) consisted of 5 men and 3 women, age 43.4 +I- 6.6 yrs 
who underwent aoltic valve replacement. The MR group (n=lO) consisted of 7 men and 3 
woman, age 56.2 +I- 6.6 yrs, who underwent mitral valve repair. They underwent 2D 
echocardiography before, 6 months, and 1 year after surgery. The parameters evaluated 
included end-diastolic and systolic volumes (LVEDV. LVESV). LV mass, ejection fraction 
(EF), and sphericity index. Normal sphericity index IS - 2. 
Results: At baseline, and at follow-up, all parameters in the MR group ware closer to 
normal than the AR group. This difference persists at 12months despite a more dramatic 
change in the Al group. 
Comparison of echocardiographic parametcra for Al and MR patients 
LVEDV (ml) 
(Change from 
baseline) 
LVESV (ml) 
(Change from 
baseline) 
Sphericity Index 
(Change from 
baseline) 
LV Mass(g/n?) 
(Change from 
baseline) 
EF (%) 
Pm-surgery 6-mo post-surgery lyr post-surgery 
Al MR Al rum Al MR 
223-69 123-32.9 160-67. 
.3 # 5 
(19%) 
130-50 57-l 6.0# 107-50. 
.9 1 
(16%) 
1.59-O. 1.75-0.2 1.70-O. 
2 o# 2 
(14%) 
149-27 113-21.8 105-25. 
.2 # 22+9%, 
43-5 54-w 41-a 
102.9-28. 
9# 
(19%) 
48-15X 
(16%) 
1.84-0.2# 
(4.9%) 
95-24.8#* 
(16%) 
53.. 5# 
157-69. 99.7-36.9 
6’ 
(30%) r;7%) 
6542.2 43-17.3#’ 
f (24%) 
(34%) 
1.8-0.2’ 1.91-0.3x 
(13.7%) * 
(6.9%) 
102-26. 92-1a.w 
2’ (19%) 
(32%) 
46-6 56- 5# 
Results shown as Mean-SD. * ~~0.05 v.s Baseline, # pqO.05 vs AR. 
Conclusions: LV remodeling following surgical revision in patients with chronic MA and 
AR is quite different; with the greatest changes noted after aortic valve replacement. 
These differences persist in tha late follow-up and may necessitate different approaches 
to the timing of the valve replacement in these groups of patients. 
A. Marc Grllinov. Alex S. Colafranceschi, Eugene H. Blackstone, Christiano Faber, Bruce 
W. Lytle, Joseph F. Sabik. Ill, D&s M. Cosgrove, Ill, The Cleveland Clinic Foundation, 
Cleveland, OH 
Background: Degenerative mitral valve d&ease is cqrnm~n in elderly patients, and such 
patients frequently come to surgical therapy. This study explores the relationships 
between patient age and pathology, treatment, and outcome in patients having surgery 
for degenerative mitral valve disease. 
Methods: From 1965 through 1996, 1,602 patients with degenerative mitral valve dis- 
ease had mitral valve repair (n=l,399) or replacement (n=203). Age ranged from 16 to 69 
years. Trend and multivariable analyses were used to identify associations between 
increasing age and pathology, treatment, and hospital and long-term outcomes. 
Results: Older patients had more advanced cardiac disease, with greater prevalence of 
coronary artery disease (P<.OOOl) and atrial fibrillation (P<.OOOl), higher left ventricular 
mass index (P=.O2), and larger left atria ~~.OOOl). Mitral valve pathology was nwe 
severe in the elderly, with greater prevalence of leaflet (Pc.0001) and anular calcification 
(P<.OOOl). Increasing age was associated with decreased likelihood of valve repair 
(P<.OOOi) and increased hospital (P<.OOOl) and late mortality (P<.OOOl). However, 
mitral valve repair conferred a survival benefit war mitral valve replacement, and the 
magnitude of this benefit Increased with increasing patient age (Figure). 
Conclusion: The nature of degenerative drsease and associated cardiac abnormalities 
wxsens with age. Nevertheless, the elderly derive a survival benefit from mitral valve 
repair. 
9:30 a.m. 
606-2 Presence of Mitral Annular Calcification Predicts 
Improvement in Mitral Regurgitation After Aortic Valve 
Replacement for Severe Aortic Stenosis 
Maren E. Jeffery, Martin G. Keane, Craig H. Scott, Susan E. Wiegers. Michael A. Acker, 
Hospital of the University of Pennsylvania, Philadelphia, PA 
Backqround: A majority of patients with severe aortic stenosis (AS) also have varying 
degrees of mitral regurgitation (MR). Replacement of both valves simultaneously is asso- 
ciated with at least twofold greater mortality. MR SOmetimes improves with replacement 
of the aortic valve (AV) alone, but preoperative characteristics that predict this improve- 
ment are unknown. We assessed preoperative echocardiographic variables that predict 
patients with improvement in MR after Isolated aortic valve replacement (AVR) for severe 
AS. 
Methods: We revlewd pra- and postoperative echocardiograms from 62 p&rents with 
severe AS and mild or greater MR who subsequently underwent isolated AVR. Patients 
with postoperative improvement in MR were compared to those wth stable or worsening 
postoperative MR Preoperative variables evaluated included presence of mitral annular 
calcification (MAC), left atrial size, and measures of left ventrwlar size, wall thickness 
and function. 
&I& Twenty-srx pabents (41.9%) were female and 36 (56.1%) were male, with a 
mean age of 73.Oi13.6 yrs. Forty patients (64.5%) had pOstoperatIve imprOVam?nt in 
MR followng isolated AVR. while MR became worse in 6 patients (12.9%) and remained 
the same in 14 (22.6%). There were no statistically significant differences in age, gander, 
preoperative AV area, preoperative left atrial size, or preoperatwe left ventricular size, 
wall thickness or function between the two groups. However, MAC was rnwe frequently 
present in those patients who had postoperative improvement rn MR. Of the 40 patients 
with improvement I” MR, 32 (80%) had MAC, whereas only 9 of the 22 patients (41%) 
with stable or worsening MR had MAC. (Odds ratio for worsening MR In the presence of 
MArZ0.17, CI=O.O5, 0.63; p=O.O02). 
Conclusion: Presence of MAC correlates with a high probability of improvement in MR 
after isolated AVR for severe AS. This is useful in identifying patients who may not need 
bivalve replacements, thereby reducing operative risk. 
